日报更新时间：04-20 10:53
周报更新时间：04-18 04:06
今开价：169.58
最高价：171.16
成交量：682173.0
昨收价：168.74
最低价：168.88
最新价：170.43
英文名称：Zoetis
行业：医疗
简介：硕腾公司于2012年7月在美国特拉华州成立，是全球领先的最大的动物保健药和疫苗公司之一
电话：1-973-8227000
硕腾公司是世界上最大的宠物和家畜用药品和疫苗厂商，是世界最大的药品制造商辉瑞公司的上市子公司，辉瑞公司占83％的股份（已出售大部分），硕腾公司在全球70个国家运营，最近扩展到东南亚和中国一带。Zoetis Inc.从事家畜与宠物的动物保健药品与疫苗的开发、制造与销售，Zoetis业务经营以区域分为四个部门，分别为美国、欧洲/非洲/中东、加拿大/拉美，亚洲/太平洋。Zoetis 提供的产品包括疫苗、杀寄生虫药、抗感染、加药饲料添加剂及其他药剂，用于家畜与宠物，其直接竞争对手包括默克、赛诺菲、美国礼来等大型制药公司旗下的动物保健部门。硕腾公司Zoetis(ZTS)历史百科： 在20世纪50年代，辉瑞开始研究包括土霉素在内的多种药物。辉瑞产品的化学工程师John McKeen发现其对家畜有效。1952年，辉瑞公司农业事业部（Pfizer Agriculture Division）成立，在印第安纳州特雷霍特开设了732英亩的研发基地Vigo。 1952年，辉瑞农业部门（Pfizer Agriculture Division）成立，是为硕腾公司Zoetis Inc.前身； 1955年，Pfizer Agriculture Division收购葛兰素史克(GlaxoSmithKline)的诺登实验室（Norden Laboratories）； 1988年，辉瑞农业部门更名为辉瑞动物健康（Pfizer Animal Health）； 1995年，对葛兰素史克公司的诺登实验室（Norden Laboratories）的收购使辉瑞动保部门扩展到包括家养宠物在内的小动物护理领域； 2003年，第2个研发中心在密歇根州卡拉马祖成立。 2003年，辉瑞以60亿美元的股票期权收购法玛西亚公司（Pharmacia Corporation）； 2007-2011年，Pfizer Animal Health先后收购Embrex Inc、Catapult Genetics、Bovigen、Wyeth、Fort Dodge Animal Health、Vetnex Animal Health Ltd、Synbiotics Corporation、Microtek、King Pharmaceuticals、Alpharma等公司； 2012年8月13日，辉瑞将动物保健业务（Pfizer Animal Health）分拆独立成一家公司——Zoetis Inc.； 2013年2月1日，硕腾公司（Zoetis Inc.）IPO，发行价26美元，融资22亿美元； 2013年5月22日，辉瑞公司计划出售其在硕腾公司的多数股权，股东将有权选择将他们的辉瑞股票置换成硕腾股票，出售硕腾的计划与辉瑞公司最近清退其它非医药子公司的决定相一致，这些决定的目的是努力节省成本、筹集资金并还清债务。JPMorgan Chase、Bank of America Merrill Lynch、Goldman Sachs & Co.、Morgan Stanley为主承销商； 2014年11月，Bill Ackman公布Pershing Square Capital Management已买进Zoetis公司8.5%股权，约4180万股； 2014年11月17日，硕腾公司宣布将以2.55亿美金收购雅培实验室Abbott Laboratories的宠物药品组合； 2015年11月，Zoetis Inc.宣布以7.65亿美金收购水产品疾病治疗药物公司——Pharamaq； 2017年7月31日，Zoetis 以8500万美元完成收购 Nexvet Biopharma。 2018年5月16日，Zoetis宣布以20亿美元收购兽医诊断公司Abaxis。硕腾公司Zoetis(ZTS)旗下产品包括： Apoquel Bovi-Shield Gold Cerenia Convenia Dectomax Draxxin Excede Excenel Histostat Inovocox Mycitracin Palladia Pirsue A180 Revolution Pet Medicine Rimadyl Simplicef Slentrol Solitude IGR Spectramast Stellamune Stronghold Synulox
| 交易日期 | 交易人 | 职位 | 类型 | 交易份额 | 价格 |
|---|---|---|---|---|---|
| 2019-06-12 | Reed Willie M | Director | Sell | 1900 | 110.58 |
| 2019-05-09 | Lagano Roxanne | Officer | Buy | 29453 | -- |
| 2019-05-09 | Lagano Roxanne | Officer | Sell | 29453 | 101.65 |
| 2019-02-13 | Lewis (Clinton A Jr) | Officer | Sell | 6125 | 91.96 |
| 2019-02-13 | Lewis (Clinton A Jr) | Officer | Buy | 3567 | -- |
| 2018-08-13 | Alaix (Juan Ramon) | Chief Executive Officer | Sell | 135000 | 91.55 |
| 2018-08-06 | Trawicki (Roman) | Officer | Sell | 8266 | 92.53 |
| 2018-08-06 | Trawicki (Roman) | Officer | Buy | 4688 | -- |
| 2018-03-08 | Trawicki (Roman) | Officer | Sell | 8568 | 83.10 |
| 2018-03-08 | Trawicki (Roman) | Officer | Buy | 8568 | -- |
| 2018-02-26 | Khosla (Sanjay) | Director | Sell | 1203 | 81.67 |
| 2018-02-26 | Khosla (Sanjay) | Director | Buy | 3771 | -- |
| 机构持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| MFS Investment Management KK | 7801894 | 1.63% | 109647 | 1.43% | 2019-03-31 |
| BlackRock Fund Advisors | 12203473 | 2.55% | -1210365 | -9.02% | 2019-07-31 |
| Vanguard Investments Australia Ltd | 13360891 | 2.79% | 62570 | 0.47% | 2019-07-31 |
| Morgan Stanley - Brokerage Accounts | 13785853 | 2.88% | 127988 | 0.94% | 2019-03-31 |
| AllianceBernstein L.P. | 14987889 | 3.13% | 1441288 | 10.64% | 2019-03-31 |
| State Farm Mutual Automobile Ins Co | 19124444 | 4.00% | -- | -- | 2019-03-31 |
| State Street Corporation | 20014594 | 4.18% | 803471 | 4.18% | 2019-03-31 |
| Vanguard Group Inc | 36419410 | 7.61% | 48286 | 0.13% | 2019-03-31 |
| BlackRock Inc | 37486408 | 7.83% | 795558 | 2.17% | 2019-03-31 |
| Polen Capital | 10102190 | 2.11% | 548623 | 5.74% | 2019-03-31 |
| Capital Research and Management Company | 9956900 | 2.08% | 1610733 | 19.30% | 2019-07-31 |
| Morgan Stanley Investment Management Ltd | 8930182 | 1.87% | 379113 | 4.43% | 2019-03-31 |
| Massachusetts Financial Services Company | 7801894 | 1.63% | 109647 | 1.43% | 2019-03-31 |
| State Street Global Advisors | 7857921 | 1.64% | 12772 | 0.16% | 2019-07-31 |
| Fidelity Management and Research Company | 8127077 | 1.70% | 882638 | 12.18% | 2019-03-31 |
| FMR Inc | 8127931 | 1.70% | 882183 | 12.18% | 2019-03-31 |
| Fidelity Management & Research Company | 8234648 | 1.72% | -928118 | -10.13% | 2019-07-31 |
| Capital World Investors | 8700758 | 1.82% | 1420895 | 19.52% | 2019-03-31 |
| ClearBridge Advisors, LLC | 8703622 | 1.82% | 15265 | 0.18% | 2019-03-31 |
| Bank of America Corporation | 8794828 | 1.84% | 546838 | 6.63% | 2019-03-31 |
| BlackRock Asset Management Canada Ltd | 14936063 | 3.12% | 16246 | 0.11% | 2019-05-31 |
| Geode Capital Management, LLC | 12455952 | 2.60% | 7013064 | 128.85% | 2018-12-31 |
| Marshall Wace North America LP | 8404482 | 1.76% | 5236402 | 165.29% | 2018-09-30 |
| Brown Advisory Holdings Inc | 6483385 | 1.35% | -112593 | -1.71% | 2018-09-30 |
| TIAA-CREF Investment Management LLC | 12880378 | 2.69% | 5974221 | 86.51% | 2018-09-30 |
| Brown Investment Advisory Incorporated | 6483010 | 1.35% | -112593 | -1.71% | 2018-09-30 |
| Goldman Sachs Group Inc | 6101066 | 1.27% | -779631 | -11.33% | 2018-09-30 |
| BlackRock Institutional Trust Company NA | 13278224 | 2.76% | -1945283 | -12.78% | 2018-06-30 |
| State Street Corp | 18470179 | 3.83% | -510333 | -2.69% | 2018-06-30 |
| AllianceBernstein LP | 13378544 | 2.77% | -114751 | -0.85% | 2018-06-30 |
| Brown Brothers Harriman & Co | 6757672 | 1.39% | -1323720 | -16.38% | 2018-03-31 |
| Winslow Capital Management, LLC | 5781112 | 1.20% | 2780535 | 92.67% | 2018-06-30 |
| Northern Trust Investments N A | 5991814 | 1.24% | 43287 | 0.73% | 2018-06-30 |
| State Street Global Advisors (Aus) Ltd | 5597959 | 1.16% | 130695 | 2.39% | 2018-09-12 |
| Waddell & Reed Investment Management Co | 5596982 | 1.16% | -611058 | -9.84% | 2018-06-30 |
| HHG PLC | 5410040 | 1.12% | 985586 | 22.28% | 2018-06-30 |
| T. Rowe Price Associates, Inc. | 5116408 | 1.06% | -4832383 | -48.57% | 2018-06-30 |
| Lazard Asset Management LLC | 4618961 | 0.95% | 54943 | 1.20% | 2018-03-31 |
| American Century Inv Mgt Inc | 5213916 | 1.08% | -331943 | -5.99% | 2018-03-31 |
| Cantillon Capital Management LLC | 5009721 | 1.03% | -347457 | -6.49% | 2017-12-31 |
| DSM Capital Partners LLC | 4020930 | 0.83% | -524459 | -11.54% | 2018-03-31 |
| Independent Franchise Partners LLP | 6495581 | 1.34% | -180109 | -2.70% | 2017-12-31 |
| ING Investment Management LLC | 5220481 | 1.07% | -195155 | -3.60% | 2017-09-30 |
| Managed Account Advisors LLC | 5626393 | 1.15% | 2008226 | 55.50% | 2017-09-30 |
| Massachusetts Financial Services Co | 7291975 | 1.50% | -71292 | -0.97% | 2017-10-31 |
| Morgan Stanley Investment Management Inc | 13553803 | 2.74% | -1731970 | -11.33% | 2016-09-30 |
| Marshall Wace Asset Management Ltd | 12647653 | 2.55% | 3487675 | 38.08% | 2016-09-30 |
| Principal Global Investors, LLC | 10016876 | 2.02% | 126708 | 1.28% | 2016-09-30 |
| Janus Capital Management LLC | 5061003 | 1.02% | 1263483 | 33.27% | 2016-09-30 |
| The Vanguard Group | 27373108 | 2.00% | 1261626548 | -- | 1999-11-30 |
| BlackRock, Inc. | 27553426 | 2.00% | 1269937404 | 0.10% | 1999-11-30 |
| Pershing Square Capital Management, L.P. | 41823145 | 2.00% | 1927628753 | 0.10% | 1999-11-30 |
| 共同基金持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| American Funds Growth Fund of Amer | 2000000 | 0.42% | 1200000 | 150.00% | 2019-06-30 |
| Vanguard 500 Index Fund | 9419359 | 1.97% | 93886 | 1.01% | 2019-06-30 |
| American Funds New Perspective Fund | 5525000 | 1.15% | -- | -- | 2019-06-30 |
| SPDR | 5334810 | 1.11% | 4879 | 0.09% | 2019-07-31 |
| Vanguard Institutional Index Fund | 4469386 | 0.93% | -34833 | -0.77% | 2019-06-30 |
| MS INVF Global Brands Fund | 4125874 | 0.86% | 24029 | 0.59% | 2019-03-31 |
| iShares Core S&P 500 ETF | 3517142 | 0.73% | -1734 | -0.05% | 2019-07-30 |
| MFS Growth Fund | 3466985 | 0.72% | 22008 | 0.64% | 2019-06-30 |
| Vanguard Growth Index Fund | 3420281 | 0.71% | 112228 | 3.39% | 2019-06-30 |
| Fidelity | 3304764 | 0.69% | 56716 | 1.75% | 2019-06-30 |
| CREF Growth Account | 3160744 | 0.66% | -266301 | -7.77% | 2019-05-31 |
| ClearBridge Large Cap Growth Fund | 3048996 | 0.64% | 137045 | 4.71% | 2019-06-30 |
| AB Large Cap Growth Fund | 2917778 | 0.61% | 24890 | 0.86% | 2019-06-30 |
| Health Care Select Sector SPDR | 2409813 | 0.50% | 4480 | 0.19% | 2019-07-31 |
| Janus Henderson Forty Fund | 2287377 | 0.48% | -- | -- | 2019-06-30 |
| Janus Concentrated Growth Tr | 2287377 | 0.48% | -- | -- | 2019-06-30 |
| MainStay Large Cap Growth Fund | 2135040 | 0.45% | -39700 | -1.83% | 2019-05-31 |
| State Street S&P 500 Index Fund | 2058612 | 0.43% | 12200 | 0.60% | 2019-06-30 |
| Vanguard Total Stock Market Index Fund | 13170846 | 2.75% | 62571 | 0.48% | 2019-06-30 |
| MS INVF US Advantage Fund | 1956758 | 0.41% | -199572 | -9.26% | 2019-03-31 |
| iShares Core MSCI AllCntry Wld exCan ETF | 3503433 | 0.73% | 1148 | 0.03% | 2019-05-23 |
| iShares MSCI World ETF | 3503433 | 0.73% | 1148 | 0.03% | 2019-05-23 |
| iShares Core S&P 500 ETF (CAD-Hedged) | 3516922 | 0.73% | 3157 | 0.09% | 2019-05-30 |
| iShares S&P 500 ETF | 3516922 | 0.73% | 3157 | 0.09% | 2019-05-30 |
| iShares Core S&P US Total Market ETF | 3516922 | 0.73% | 3157 | 0.09% | 2019-05-30 |
| iShares Core MSCI Kokusai ETF | 3516922 | 0.73% | 3157 | 0.09% | 2019-05-30 |
| CREF Stock Account | 1919727 | 0.40% | -63426 | -3.20% | 2019-02-28 |
| Undrly L&G Diversified Life | 2073742 | 0.43% | 2073742 | -- | 2018-09-30 |
| Undrly L&G Pen PMC Diversified | 2073742 | 0.43% | 2073742 | -- | 2018-09-30 |
| RI CBF AllianceBern Large Cap Gr Por | 2867498 | 0.60% | 500040 | 21.12% | 2019-01-31 |
| VA CollegeAmerica New Perspective Fd | 5325000 | 1.11% | -- | -- | 2018-12-31 |
| Vanguard Windsor | 1722747 | 0.36% | -213700 | -11.04% | 2018-12-31 |
| Pioneer Fundamental Growth Fund | 1748197 | 0.37% | -- | -- | 2018-12-31 |
| OH Putnam Fidelity Spartan 500 Index | 3599324 | 0.75% | 104143 | 2.98% | 2019-01-31 |
| Principal LargeCap Growth Fund I | 1861290 | 0.39% | -59749 | -3.11% | 2018-12-31 |
| iShares Russell Mid-Cap Growth ETF | 1597650 | 0.33% | 1914 | 0.12% | 2018-06-21 |
| MFS | 3044230 | 0.63% | 21392 | 0.71% | 2018-09-30 |
| T. Rowe Price Capital Appreciation Fund | 3608600 | 0.75% | -313138 | -7.98% | 2017-12-31 |
| AZ InvestEd Ivy Mid Cap Growth E | 1492492 | 0.31% | -105108 | -6.58% | 2018-06-30 |
| Vanguard Total Stock Mkt Idx | 12164264 | 2.52% | 47622 | 0.39% | 2018-07-31 |
| Vanguard 500 Index Inv | 8763050 | 1.82% | 12231 | 0.14% | 2018-07-31 |
| VA CollegeAmerica New Perspective 529E | 5092000 | 1.06% | 1717000 | 50.87% | 2018-06-30 |
| Vanguard Institutional Index I | 4682408 | 0.97% | 6555 | 0.14% | 2018-07-31 |
| Vanguard Growth Index Inv | 3406582 | 0.71% | -11122 | -0.33% | 2018-07-31 |
| CREF Growth R1 | 3249958 | 0.67% | 15688 | 0.49% | 2018-07-31 |
| Fidelity Spartan | 3223120 | 0.67% | 38018 | 1.19% | 2018-07-31 |
| Janus Forty S | 2897875 | 0.60% | -- | -- | 2018-06-30 |
| MFS Growth B | 2934348 | 0.61% | 109303 | 3.87% | 2018-07-31 |
| iShares Russell 1000 Growth | 1579967 | 0.32% | -1088 | -0.07% | 2018-09-12 |
| Pioneer Fundamental Growth A | 1665603 | 0.35% | 254348 | 18.02% | 2018-06-30 |
| MainStay Large Cap Growth A | 1836400 | 0.38% | -12200 | -0.66% | 2018-07-31 |
| Principal LargeCap Growth I Instl | 1944429 | 0.40% | 3169 | 0.16% | 2018-07-31 |
| RI CBF AllianceBern Large Cap Gr Port RZ | 2339268 | 0.49% | -14660 | -0.62% | 2018-07-31 |
| CREF Stock R1 | 2556750 | 0.53% | 14469 | 0.57% | 2018-07-31 |
| ClearBridge Large Cap Growth A | 2718308 | 0.56% | 9810 | 0.36% | 2018-07-31 |
| T. Rowe Price Mid-Cap Value | 1593600 | 0.33% | -550500 | -25.68% | 2018-03-31 |
| iShares Russell Mid-Cap Growth | 1597650 | 0.34% | 1914 | 0.12% | 2018-06-21 |
| T. Rowe Price Capital Appreciation | 3608600 | 0.74% | -313138 | -7.98% | 2017-12-31 |
| T. Rowe Price Mid-Cap Growth | 2500000 | 0.51% | -500000 | -16.67% | 2017-12-31 |
| Prudential Jennison Mid Cap Growth A | 1713810 | 0.35% | -18258 | -1.05% | 2017-12-31 |
| T. Rowe Price Growth Stock | 3691926 | 0.75% | -964850 | -20.72% | 2017-09-30 |
| Principal MidCap R2 | 5824083 | 1.18% | -244905 | -4.04% | 2016-12-31 |
| BBH Core Select N | 2712190 | 0.54% | -- | -- | 2017-01-31 |
| MFS Massachusetts Investors Gr Stk A | 2720074 | 0.55% | -39560 | -1.43% | 2016-12-31 |
| Strategic Advisers | 2591668 | 0.52% | 145595 | 5.95% | 2016-12-31 |
| T. Rowe Price Blue Chip Growth | 2398900 | 0.49% | -78000 | -3.15% | 2016-12-31 |
| Principal MidCap Fund | 5160151 | 1.00% | 729465 | 16.50% | 2015-10-31 |
| Vanguard Health Care Fund | 4804337 | 1.00% | -311500 | -6.10% | 2015-09-30 |
| SPDR® S&P 500® ETF Trust | 4624109 | 0.90% | -- | -- | 2015-09-30 |
| SPDR® S&P 500 ETF | 4447088 | 1.00% | 33540 | 0.80% | 2015-11-19 |
| BBH Core Select Fund | 4088849 | 0.80% | -137950 | -3.30% | 2015-10-31 |
| Morgan Stanley Inst Mid Cap Growth Port | 3057940 | 0.60% | -712672 | -18.90% | 2015-09-30 |
| MS INVF US Advantage | 2720278 | 0.60% | 285759 | 11.70% | 2015-10-31 |
| AZ InvestEd Ivy Mid Cap Growth Fund | 2449970 | 0.50% | 335129 | 15.80% | 2015-09-30 |
| Health Care Select Sector SPDR® Fund | 2329548 | 0.50% | -11530 | -0.50% | 2015-11-19 |
| Vanguard Windsor II Fund | 7629697 | 1.50% | 1727560 | 29.30% | 2015-09-30 |
| Mike B. McCallister | Mike B. McCallister is a businessperson who has been at the head of 6 different companies. He occupies the position of Non-Executive Chairman at Zoetis, Inc., Chairman & Chief Executive Officer at Humana Health Benefit Plan of Louisiana, Inc., Chairman, President & Chief Executive Officer for Humana Wisconsin Health Organization Insurance Corp., Chairman & Chief Executive Officer of Humana Employers Health Plan of Georgia, Inc. and Chairman & Chief Executive Officer of Humana Benefit Plan of Illinois, Inc. Mike B. McCallister is also on the board of 5 other companies. In his past career he held the position of Non-Executive Chairman for Humana, Inc. Mr. McCallister received an undergraduate degree from Louisiana Tech University and an MBA from Pepperdine University. |
|---|---|
| Louise M. Parent | Louise M. Parent is on the board of Zoetis, Inc., Smith College, Fidelity National Information Services, Inc. and Cold Spring Harbor Laboratory, Inc. and Of Counsel at Cleary Gottlieb Steen & Hamilton LLP. She previously occupied the position of Executive Vice President & General Counsel for American Express Co. and Executive Vice President for RiverSource Investments LLC. Ms. Parent received an undergraduate degree from Smith College and a graduate degree from Georgetown University Law Center. |
| Linda Rhodes | Founder of Aratana Therapeutics, Inc. and AlcheraBio LLC, Linda Rhodes is on the board of Zoetis, Inc. and Alliance for Contraception for Cats & Dogs. She previously held the position of Chief Scientific Officer of Aratana Therapeutics, Inc., Partner at AlcheraBio LLC and Director-Production Animal Development Projects at Merial, Inc. Linda Rhodes received a doctorate from Cornell University, an undergraduate degree from Sarah Lawrence College and a doctorate from the University of Pennsylvania School of Veterinary Medicine. |
| Robert W. Scully | Robert W. Scully is on the board of UBS AG and 7 other companies. In his past career Mr. Scully occupied the position of Managing Director & Member-Chairman Office at Morgan Stanley, Managing Director at Scully Brothers & Foss, Managing Director at Lehman Brothers, Inc. and MD, MD-Investment Banking & Capital Markets at Salomon Brothers. He received an undergraduate degree from Princeton University and an MBA from Harvard University. |
| Kristin C. Peck | Kristin C. Peck is on the board of Thomson Reuters Corp. and Reuters Transaction Services Ltd. and Executive Vice President & President-US Operations at Zoetis, Inc. In her past career Ms. Peck occupied the position of Principal at The Boston Consulting Group, Inc. and EVP-Worldwide Business Development & Innovation at Pfizer Inc. She received an undergraduate degree from Georgetown University and an MBA from Columbia Business School. |
| Andrew Fenton | Presently, Andrew Fenton is Chief Digital & Technology Officer, Executive VP at Zoetis, Inc. Mr. Fenton previously held the position of Partner at Ernst & Young Global Ltd. and Partner at Ernst & Young LLP (a subsidiary of Ernst & Young Global Ltd.) and Chief Information Officer & Senior Vice President of Warner Chilcott Plc. He received an undergraduate degree from British Columbia Institute of Technology. |
| William C. Steere | William C. Steere is on the board of Zoetis, Inc. and NYU Elaine A. & Kenneth G. Langone Medical Center and Vice Chairman & President at The New York Botanical Garden. In his past career he held the position of Chairman-Emeritus at Pfizer Inc. He received an undergraduate degree from Stanford University. |
| Paul M. Bisaro | Paul M. Bisaro is a businessperson who has been at the head of 11 different companies. He holds the position of Executive Chairman for Amneal Pharmaceuticals, Inc. He is also on the board of Zoetis, Inc., Anda, Inc. (former President & Director), Columbus School of Law and Zimmer US, Inc. In his past career he was Director at Allergan Plc Executive Chairman of Forest Laboratories, Inc. Chairman, President & Chief Executive Officer of Actavis, Inc. and President & Chief Executive Officer at Warner Chilcott Plc (which are all subsidiaries of Allergan Plc), Associate at Winston & Strawn LLP, Associate for Bishop, Cook, Purcell & Reynolds, Senior Consultant at Arthur Andersen LLP, President, Chief Executive Officer & Director at Impax Laboratories LLC, President for Teva Women's Health, Inc., President, Chief Operating Officer & Director at Barr Pharmaceuticals, Inc., President & Chief Operating Officer for Barr Laboratories, Inc. and Chairman for Association for Accessible Medicines. Mr. Bisaro received an undergraduate degree from the University of Michigan and a graduate degree from The Catholic University of America. |
| Frank A. D'Amelio | Currently, Frank A. D'Amelio holds the position of Chief Financial Officer & EVP-Business Operations at Pfizer Inc. He is also on the board of Humana, Inc., Zoetis, Inc. (former Chairman), Independent College Fund of New Jersey and The Gillen Brewer School. He previously was Principal at AT&T, Inc., Chief Operating Officer & Director at Lucent Technologies, Inc., Chief Administrative Officer & SEVP-Integration at Alcatel-Lucent SAS, Chief Administrative Officer & Senior Executive VP at Nokia of America Corp. and Principal at Bell Laboratories. Frank A. D'Amelio received an undergraduate degree from Saint Peter's University and an MBA from St. John's University. |
| Sanjay Khosla | Presently, Sanjay Khosla is Chief Executive Officer at Bunnik LLC. Mr. Khosla is also on the board of 4c Insights, Inc., Zoetis, Inc. and CarePredict, Inc. and Senior Fellow at Kellogg School of Management. In the past he was President-Developing Markets at Kraft Foods, Inc. (New Jersey), Managing Director at Fonterra Brands Ltd., President at Kraft International Commercial and Senior Vice President-Global Beverages at Unilever United States, Inc. Mr. Khosla received an undergraduate degree from Indian Institute of Technology New Delhi. |
| Gregory Norden | Currently, Gregory Norden holds the position of Managing Director at G9 Capital Group LLC. He is also on the board of 6 other companies. In the past he held the position of Audit Manager at Arthur Andersen LLP, Chief Financial Officer& Executive Vice President at Wyeth Pharmaceuticals LLC, Vice President-Finance at Ayerst Laboratories, Inc. and Chief Financial Officer & Senior Vice President for Wyeth Corp. Mr. Norden received a graduate degree from Long Island University and an undergraduate degree from State University of New York College at Plattsburgh. |
| John O'Connor | Currently, John O'Connor holds the position of Senior VP-Finance & Treasury at Zoetis, Inc. He previously held the position of Research Associate at Morgan Stanley & Co. LLC. |
| Juan Ram�0�1�0�6n Alaix | Presently, Juan Ram�0�1�0�6n Alaix is Chief Executive Officer & Director at Zoetis, Inc. He is also on the board of International Federation for Animal Health (former President & Director). In his past career he occupied the position of President-Spain Market at Pharmacia Spain SA. Mr. Alaix received an undergraduate degree from Universidad Complutense de Madrid. |
| Heidi C. Chen | Heidi C. Chen is Secretary, Executive VP & General Counsel of Zoetis, Inc. She is also on the board of Asian American Legal Defense & Education Fund. In the past she was Associate for Hughes Hubbard & Reed LLP and Assistant General Counsel at Pfizer Inc. Ms. Chen received an undergraduate degree from Yale University and a graduate degree from Cornell Law School. |
| Heidi C. Chen | Heidi C. Chen is Secretary, Executive VP & General Counsel of Zoetis, Inc. She is also on the board of Asian American Legal Defense & Education Fund. In the past she was Associate for Hughes Hubbard & Reed LLP and Assistant General Counsel at Pfizer Inc. Ms. Chen received an undergraduate degree from Yale University and a graduate degree from Cornell Law School. |
| Catherine Ann Knupp | Presently, Catherine Ann Knupp is Executive VP, President-Research & Development at Zoetis, Inc. In her past career she held the position of Vice President-Michigan laboratories at Pfizer Inc. and Vice President at Pfizer Global Research & Development (a subsidiary of Pfizer Inc.) and Vice President-Chemical Manufacturing Controls at Bristol-Myers Squibb Co. She received a doctorate, a graduate degree and an undergraduate degree from the University of Illinois and an undergraduate degree from Western Illinois University. |
| Roxanne Lagano | Currently, Roxanne Lagano is Chief Human Resources Officer & EVP-Communications at Zoetis, Inc. In her past career she occupied the position of Principal at Schulte Roth & Zabel LLP and Manager-Tax Planning at Pfizer Inc. She received an undergraduate degree from Long Island University, a graduate degree from Maurice A. Deane School of Law at Hofstra University and a graduate degree from Hofstra University. |
| Clinton A. Lewis | Clinton A. Lewis is on the board of International Paper Co. and Executive VP & President-International Operations at Zoetis, Inc. and Treasurer at International Federation for Animal Health Europe. He previously was Senior Vice President-Sales for Pfizer Inc., Chairman for Animal Health Institute and Treasurer for Animal Health Europe. He received an undergraduate degree from Fairfield University and an MBA from Fairleigh Dickinson University. |
| Willie M. Reed | Willie M. Reed is President at The American Association of Avian Pathologists, Inc. Dr. Reed is also on the board of Zoetis, Inc. and Chairman-Research Council at American Veterinary Medical Association and Dean at Purdue University. In the past Willie M. Reed was President at American Association of Veterinary Laboratory Diagnosticians and President at Association of American Veterinary Medical College. Dr. Reed received a doctorate from Purdue University and a doctorate from Tuskegee University. |
| Glenn C. David | Currently, Glenn C. David is Chief Financial Officer & Executive Vice President for Zoetis, Inc. In his past career Mr. David occupied the position of Vice President-Finance & US Primary Care at Pfizer Inc. Mr. David received an undergraduate degree from State University of New York at Binghamton and an MBA from New York University. |
| Katherine H. Walden | Currently, Katherine H. Walden is Chief Compliance Officer & Governance Counsel at Zoetis, Inc. |
| Steven Frank | Currently, Steven Frank is Head-Investor Relations of Zoetis, Inc. |
abu_quant
扫一扫关注阿布量化
热门推荐
全部评论 0
暂无评论